Breast Cancer Clinical Trial
Collection of Blood Specimens for Circulating Tumor Cell Analysis
Summary
Objective: To test the sensitivity of a proprietary novel filtration device designed to capture and concentrate circulating tumor cells (CTCs).
Eligibility Criteria
Inclusion Criteria:
Age > 18 years of age
Written informed consent obtained
Confirmed diagnosis of stage 2-4 breast, prostate, or colorectal cancer, (OR) no prior history of cancer
Stage 2-4 treatment naive, metastatic, secondary, and recurrent cancer patients
Able to undergo blood collection prior to initiation of chemotherapy treatment, (OR) able to provide blood sample if subject is a non-cancer control subject
Exclusion Criteria:
Patients unable to understand the research protocol and/or provide informed consent.
Patients with known immunodeficiency, or pregnancy.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Lawrence Massachusetts, 01841, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.